 Outlook Therapeutics Inc NASDAQ:OTLK has announced the appointments of Dr Surendra Sharma as senior vice president of medical affairs and Glen Olsheim as executive director of commercial excellence as it grows its leadership team. The biopharmaceutical company said Sharma has more than 15 years of experience in the pharmaceutical and biotechnology industries leading corporate alliances among research and development RD, commercial, marketing and business stakeholders. 